To determine the correlation between CEMIP expression levels and clinicopathological features, we first characterized CEMIP expression via immunohistochemistry analysis of paraffin sections of liver tissues obtained from the primary tumors (PTs) of HCC patients with lung metastases (20 samples) or no metastases (56 samples). Here, CEMIP is linked to hepatocellular carcinoma.